Literature DB >> 20194495

PrP conformational transitions alter species preference of a PrP-specific antibody.

Wen-Quan Zou1, Jan Langeveld, Xiangzhu Xiao, Shugui Chen, Patrick L McGeer, Jue Yuan, Michael C Payne, Hae-Eun Kang, John McGeehan, Man-Sun Sy, Neil S Greenspan, David Kaplan, Gong-Xian Wang, Piero Parchi, Edward Hoover, Geoff Kneale, Glenn Telling, Witold K Surewicz, Qingzhong Kong, Jian-Ping Guo.   

Abstract

The epitope of the 3F4 antibody most commonly used in human prion disease diagnosis is believed to consist of residues Met-Lys-His-Met (MKHM) corresponding to human PrP-(109-112). This assumption is based mainly on the observation that 3F4 reacts with human and hamster PrP but not with PrP from mouse, sheep, and cervids, in which Met at residue 112 is replaced by Val. Here we report that, by brain histoblotting, 3F4 did not react with PrP of uninfected transgenic mice expressing elk PrP; however, it did show distinct immunoreactivity in transgenic mice infected with chronic wasting disease. Compared with human PrP, the 3F4 reactivity with the recombinant elk PrP was 2 orders of magnitude weaker, as indicated by both Western blotting and surface plasmon resonance. To investigate the molecular basis of these species- and conformer-dependent preferences of 3F4, the epitope was probed by peptide membrane array and antigen competition experiments. Remarkably, the 3F4 antibody did not react with MKHM but reacted strongly with KTNMK (corresponding to human PrP-(106-110)), a sequence that is also present in cervids, sheep, and cattle. 3F4 also reacted with elk PrP peptides containing KTNMKHV. We concluded that the minimal sequence for the 3F4 epitope consists of residues KTNMK, and the species- and conformer-dependent preferences of 3F4 arise largely from the interactions between Met(112) (human PrP) or Val(115) (cervid PrP) and adjacent residues.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20194495      PMCID: PMC2859550          DOI: 10.1074/jbc.M109.088831

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Membrane environment alters the conformational structure of the recombinant human prion protein.

Authors:  M Morillas; W Swietnicki; P Gambetti; W K Surewicz
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

2.  Antibody binding defines a structure for an epitope that participates in the PrPC-->PrPSc conformational change.

Authors:  Z F Kanyo; K M Pan; R A Williamson; D R Burton; S B Prusiner; R J Fletterick; F E Cohen
Journal:  J Mol Biol       Date:  1999-11-05       Impact factor: 5.469

Review 3.  Affinity, complementarity, cooperativity, and specificity in antibody recognition.

Authors:  N S Greenspan
Journal:  Curr Top Microbiol Immunol       Date:  2001       Impact factor: 4.291

4.  Combinatorial control of prion protein biogenesis by the signal sequence and transmembrane domain.

Authors:  S J Kim; R Rahbar; R S Hegde
Journal:  J Biol Chem       Date:  2001-05-18       Impact factor: 5.157

5.  Preferential binding of fd gene 5 protein to tetraplex nucleic acid structures.

Authors:  A W Oliver; I Bogdarina; E Schroeder; I A Taylor; G G Kneale
Journal:  J Mol Biol       Date:  2000-08-18       Impact factor: 5.469

6.  Identification of an epitope in the C terminus of normal prion protein whose expression is modulated by binding events in the N terminus.

Authors:  R Li; T Liu; B S Wong; T Pan; M Morillas; W Swietnicki; K O'Rourke; P Gambetti; W K Surewicz; M S Sy
Journal:  J Mol Biol       Date:  2000-08-18       Impact factor: 5.469

7.  Conformation of PrP(C) on the cell surface as probed by antibodies.

Authors:  Estelle Leclerc; David Peretz; Haydn Ball; Laura Solforosi; Giuseppe Legname; Jiri Safar; Ana Serban; Stanley B Prusiner; Dennis R Burton; R Anthony Williamson
Journal:  J Mol Biol       Date:  2003-02-14       Impact factor: 5.469

8.  Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics.

Authors:  Ignazio Cali; Rudolph Castellani; Amer Alshekhlee; Yvonne Cohen; Janis Blevins; Jue Yuan; Jan P M Langeveld; Piero Parchi; Jiri G Safar; Wen-Quan Zou; Pierluigi Gambetti
Journal:  Brain       Date:  2009-09-04       Impact factor: 13.501

9.  Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay.

Authors:  J D Wadsworth; S Joiner; A F Hill; T A Campbell; M Desbruslais; P J Luthert; J Collinge
Journal:  Lancet       Date:  2001-07-21       Impact factor: 79.321

10.  Acidic pH and detergents enhance in vitro conversion of human brain PrPC to a PrPSc-like form.

Authors:  Wen-Quan Zou; Neil R Cashman
Journal:  J Biol Chem       Date:  2002-08-02       Impact factor: 5.157

View more
  40 in total

1.  Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease.

Authors:  Piero Parchi; Maura Cescatti; Silvio Notari; Walter J Schulz-Schaeffer; Sabina Capellari; Armin Giese; Wen-Quan Zou; Hans Kretzschmar; Bernardino Ghetti; Paul Brown
Journal:  Brain       Date:  2010-09-07       Impact factor: 13.501

2.  Characterization of the prion protein in human urine.

Authors:  Ayuna Dagdanova; Serguei Ilchenko; Silvio Notari; Qiwei Yang; Mark E Obrenovich; Kristen Hatcher; Peter McAnulty; Lequn Huang; Wenquan Zou; Qingzhong Kong; Pierluigi Gambetti; Shu G Chen
Journal:  J Biol Chem       Date:  2010-07-29       Impact factor: 5.157

3.  Reiterating the epitope specificity of prion-specific mAb 3F4.

Authors:  Richard Kascsak
Journal:  J Biol Chem       Date:  2010-05-14       Impact factor: 5.157

4.  Disease-associated prion protein in neural and lymphoid tissues of mink (Mustela vison) inoculated with transmissible mink encephalopathy.

Authors:  D A Schneider; R D Harrington; D Zhuang; H Yan; T C Truscott; R P Dassanayake; K I O'Rourke
Journal:  J Comp Pathol       Date:  2012-05-16       Impact factor: 1.311

5.  Cellular prion protein regulates its own α-cleavage through ADAM8 in skeletal muscle.

Authors:  Jingjing Liang; Wei Wang; Debra Sorensen; Sarah Medina; Sergei Ilchenko; Janna Kiselar; Witold K Surewicz; Stephanie A Booth; Qingzhong Kong
Journal:  J Biol Chem       Date:  2012-03-23       Impact factor: 5.157

6.  Characterization of conformation-dependent prion protein epitopes.

Authors:  Hae-Eun Kang; Chu Chun Weng; Eri Saijo; Vicki Saylor; Jifeng Bian; Sehun Kim; Laylaa Ramos; Rachel Angers; Katie Langenfeld; Vadim Khaychuk; Carla Calvi; Jason Bartz; Nora Hunter; Glenn C Telling
Journal:  J Biol Chem       Date:  2012-09-04       Impact factor: 5.157

Review 7.  Molecular biology and pathology of prion strains in sporadic human prion diseases.

Authors:  Pierluigi Gambetti; Ignazio Cali; Silvio Notari; Qingzhong Kong; Wen-Quan Zou; Witold K Surewicz
Journal:  Acta Neuropathol       Date:  2010-11-07       Impact factor: 17.088

Review 8.  Prions: Beyond a Single Protein.

Authors:  Alvin S Das; Wen-Quan Zou
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

9.  Unaltered prion protein expression in Alzheimer disease patients.

Authors:  Eri Saijo; Stephen W Scheff; Glenn C Telling
Journal:  Prion       Date:  2011-04-01       Impact factor: 3.931

10.  A case of Gerstmann-Sträussler-Scheinker disease with a novel six octapeptide repeat insertion.

Authors:  A Vital; J-L Laplanche; J-R Bastard; X Xiao; W-Q Zou; C Vital
Journal:  Neuropathol Appl Neurobiol       Date:  2011-08       Impact factor: 8.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.